Published in Gastroenterology on August 01, 2005
GATA4 is essential for jejunal function in mice. Gastroenterology (2008) 1.39
Mutations of a Drosophila NPC1 gene confer sterol and ecdysone metabolic defects. Genetics (2005) 1.09
Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype. Genomics Insights (2009) 0.96
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids (2011) 0.90
Recent advances in vitamin E metabolism and deficiency. Eur J Pediatr (2006) 0.90
Combination therapy in cholesterol reduction: focus on ezetimibe and statins. Vasc Health Risk Manag (2008) 0.89
Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities. Vasc Health Risk Manag (2008) 0.85
Diet and age interactions with regards to cholesterol regulation and brain pathogenesis. Curr Gerontol Geriatr Res (2010) 0.83
Extensive expression differences along porcine small intestine evidenced by transcriptome sequencing. PLoS One (2014) 0.81
Cholesterol: from feeding to gene regulation. Genes Nutr (2007) 0.81
Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus. Eur J Nutr (2015) 0.78
Recent advances in small bowel diseases: Part II. World J Gastroenterol (2012) 0.78
Ileal apical Na+-dependent bile acid transporter ASBT is upregulated in rats with diabetes mellitus induced by low doses of streptozotocin. Am J Physiol Gastrointest Liver Physiol (2010) 0.77
Plant Sterols, Stanols, and Sitosterolemia. J AOAC Int (2015) 0.75
Standardization of PCR-RFLP analysis of nsSNP rs1468384 of NPC1L1 gene. Indian J Hum Genet (2008) 0.75
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial. BMC Res Notes (2012) 0.75
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med (2012) 1.54
Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology (2008) 1.22
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology (2008) 1.16
Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology (2004) 1.15
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta (2009) 1.13
Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics (2002) 1.11
Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. J Lipid Res (2004) 1.07
Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology (2002) 1.03
Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem (2012) 1.03
Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res (2013) 1.01
Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res (2005) 1.00
Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects. Am J Physiol Gastrointest Liver Physiol (2005) 0.99
Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hepatology (2007) 0.98
Phospholipid transfer protein-deficient mice absorb less cholesterol. Arterioscler Thromb Vasc Biol (2007) 0.97
Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci (2008) 0.97
Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis (2011) 0.97
Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice. Hepatology (2002) 0.94
Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta (2009) 0.93
Mitochondria in chronic liver disease. Curr Drug Targets (2011) 0.93
Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology (2005) 0.91
Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res (2005) 0.91
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids (2011) 0.90
Isolation and primary culture of rat hepatic cells. J Vis Exp (2012) 0.89
A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways. J Lipids (2012) 0.87
Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones. Gastroenterology (2004) 0.87
Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice. Eur J Clin Invest (2010) 0.86
Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation. J Lipid Res (2004) 0.86
New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Invest (2013) 0.85
Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest (2013) 0.85
Lack of the intestinal Muc1 mucin impairs cholesterol uptake and absorption but not fatty acid uptake in Muc1-/- mice. Am J Physiol Gastrointest Liver Physiol (2004) 0.84
Estradiol increases the anorectic effect of central apolipoprotein A-IV. Endocrinology (2010) 0.84
Medicinal treatments of cholesterol gallstones: old, current and new perspectives. Curr Med Chem (2009) 0.84
Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats. Physiol Behav (2009) 0.83
Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology (2006) 0.83
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants. Free Radic Biol Med (2007) 0.82
Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review. Curr Med Chem (2014) 0.81
A novel therapeutic effect of statins on nephrogenic diabetes insipidus. J Cell Mol Med (2015) 0.81
Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol (2012) 0.81
Apolipoprotein E reduces food intake via PI3K/Akt signaling pathway in the hypothalamus. Physiol Behav (2011) 0.81
Food-entrained rhythmic expression of apolipoprotein E expression in the hypothalamus of rats. Brain Res (2009) 0.80
Current views on genetics and epigenetics of cholesterol gallstone disease. Cholesterol (2013) 0.80
Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation? Hepatology (2012) 0.80
Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal. Am J Physiol Gastrointest Liver Physiol (2010) 0.80
Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice. Eur J Clin Invest (2014) 0.79
Assessing gastrointestinal symptoms and perception, quality of life, motility, and autonomic neuropathy in clinical studies. J Gastrointestin Liver Dis (2009) 0.78
Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism. J Lipid Res (2010) 0.77
Excess cholesterol and fat in the diet: a dangerous liaison for energy expenditure and the liver. Hepatology (2013) 0.76
Endogenous elevation of plasma cholecystokinin does not prevent gallstones. Eur J Clin Invest (2015) 0.76
The gallbladder: innocent bystander or major factor in cholesterol-gallstone formation? J Lab Clin Med (2005) 0.75
HDL receptor SR-BI and cholesterol gallstones. Hepatology (2002) 0.75